ArticleLeukemia2022
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
Sophia Adamia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleLeukemia2022
Sophia Adamia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.